Bradley, HazelMomodu, Rametu OmamegbeSchool of Public HealthFaculty of Community and Health Sciences2013-11-212026-06-102010/04/112010/04/112013-11-212026-06-102008https://hdl.handle.net/10566/23210Magister Public Health - MPHMalaria is a health, social and economic burden in Nigeria and consistently ranks amongst the four most common causes of childhood deaths. Treatment of malaria is usually started at home; care is only sought from the health facility when the treatment is ineffective (McCombie, 1996). Patent medicine vendors (PMVs) have been identified as a widely patronized source for drugs used in the home treatment of malaria (Breiger et al, 2001; Goodman, et al, 2007; Salako et al, 2001). Inadequate or poor knowledge and practices in the use of anti-malaria drugs (AMDs) increases morbidity and mortality, undermines therapeutic efficacy, and promotes the emergence and spread of drugresistant malaria. Aim: The aim of the study was to describe and quantify the knowledge and self-reported practices of PMVs in the use of antimalarials, particularly artemisinin-based combination therapies (ACTs), in a poor urban community in Lagos state, Nigeria.enMalariaPatent medicine vendorsOver-the-counter drugsPrescription-only medicinesArtemisinin-based combination therapyAnti-malaria drugAnti-malaria treatment policyHome management of malariaNigeriaThesisUniversity of the Western Cape